Homenewsabout usContact UsWebsite
Welcome to the
Cipla Press Office
Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support.
Follow us:

Latest news

Cipla SA signs agreement for anti-psychotic drugAs part of its quest to provide access to life-saving medication and making a difference in the lives of patients, Cipla Medpro, wholly-owned subsidiary of Cipla Limited, India (Cipla) and South Africa's third-largest pharmaceutical company in the private sector, recently concluded an exclusive agreement securing originator and authorised generic brands of an atypical antipsychotic drug, Quetiapine. 13 Feb 2020 Read more

The future of HIV treatment is in empowering patientsCipla, South Africa's third-largest pharmaceutical manufacturer, hosted an HIV/AIDS workshop in Sandton on Wednesday, ahead of World AIDS Day on 1 December 2019. 6 Dec 2019 Read more

The Medicines Patent Pool announces new licensee for HIV paediatric treatmentOn World AIDS Day, the Medicines Patent Pool (MPP) announced a sublicence agreement with Indian manufacturing partner Cipla for the development, manufacture and supply of HIV treatment lopinavir (LPV) and ritonavir (RTV or r) individually or in combination, for paediatric use. 6 Dec 2019 Read more

Multi-faceted community healthcare hub launched at Bellville taxi rankThe Cipla Foundation, in collaboration with the Greater Tygerberg Partnership has launched a new community-based healthcare hub at the Bellville taxi rank that will provide primary healthcare services, eyecare and a chronic medicine pick-up point to the scores of commuters that pass through this area on a daily basis. 3 Dec 2019 Read more

Cipla Foundation brings chronic medicine closer to TembisansCipla Foundation has secured funding from the US Government from the US president's Emergency Plan for Aids Relief (PEPFAR), through the United States Agency for International Development (USAID) on 4 November. 25 Nov 2019 Read more

More news...

Contact Cipla

Tel: +27 21 943 4200
Customer Care: 080 222 6662